|Bid||12.20 x N/A|
|Ask||12.50 x N/A|
|Day's Range||11.70 - 11.70|
|52 Week Range||6.55 - 27.00|
|Beta (5Y Monthly)||1.27|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 27, 2023 - Mar 03, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||66.00|
Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.
Tech stocks had as difficult a year as any sector in 2022, with the Nasdaq-100 tech index falling more than 39% over the past year. It's hard to find tech stocks, which are known for their growth, that weren't hit by falling share prices. Health Catalyst (NASDAQ: HCAT), Oracle (NYSE: ORCL), and Microsoft (NASDAQ: MSFT) are all poised to bounce back this year because their financials never really faltered, despite negative market sentiment for the sector.
In this article we are going to estimate the intrinsic value of Health Catalyst, Inc. ( NASDAQ:HCAT ) by projecting its...